Holding
Amgen Inc.AMGN
Leading biotech with $186B market cap, 71% gross margin, and 8.6% revenue growth. Equal-weighted at 5%; established biologics portfolio supports strong free cash flow generation.
weight · 5.00%·sector · Healthcare
SPY+0.17%QQQ+0.03%NVDA+4.01%MSFT+0.05%AAPL−1.27%GOOGL+1.72%META+0.53%AMZN−1.09%TSLA+0.63%AVGO−1.08%SPY+0.17%QQQ+0.03%NVDA+4.01%MSFT+0.05%AAPL−1.27%GOOGL+1.72%META+0.53%AMZN−1.09%TSLA+0.63%AVGO−1.08%